| Breakdown | Mar 2026 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 117.90M | 94.20M | 91.20M | 84.20M | 88.50M |
| Gross Profit | 67.00M | 59.10M | 57.20M | 52.10M | 62.10M |
| EBITDA | 164.20M | 132.20M | 31.30M | 16.20M | 39.60M |
| Net Income | 154.50M | 116.00M | -163.90M | 167.20M | -201.90M |
Balance Sheet | |||||
| Total Assets | 3.12B | 3.03B | 2.51B | 2.78B | 2.56B |
| Cash, Cash Equivalents and Short-Term Investments | 22.70M | 18.20M | 19.40M | 16.70M | 11.10M |
| Total Debt | 878.00M | 935.00M | 527.20M | 589.70M | 533.20M |
| Total Liabilities | 990.10M | 1.03B | 588.20M | 662.40M | 588.30M |
| Stockholders Equity | 2.13B | 2.00B | 1.92B | 2.11B | 1.97B |
Cash Flow | |||||
| Free Cash Flow | -31.30M | -4.60M | 5.60M | 15.90M | 24.50M |
| Operating Cash Flow | -31.10M | -4.00M | 5.80M | 16.20M | 24.90M |
| Investing Cash Flow | 104.90M | -384.60M | 105.10M | -31.40M | -118.30M |
| Financing Cash Flow | -88.00M | 402.60M | -108.20M | 6.30M | 9.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £4.15B | 8.95 | 7.73% | 5.85% | 15.13% | 29.20% | |
69 Neutral | £2.65B | 7.26 | 8.78% | 2.58% | 5.42% | 35.88% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £1.26B | 8.16 | 7.41% | 2.52% | 24.37% | 29.61% | |
63 Neutral | £1.99B | 12.38 | 4.48% | 3.93% | 39.97% | 39.03% | |
57 Neutral | £674.05M | -8.88 | -5.24% | 7.31% | -1.67% | -120.18% | |
51 Neutral | £235.16M | 41.40 | 5.91% | 2.71% | 4.03% | -79.67% |